CHINA PHARMA HOLDINGS INC (CPHI) Stock Income Statement
USA - NYSEARCA:CPHI - US16941T4013 - Common Stock
1.64 USD
-0.09 (-5.2%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.40M | 4.53M | 7.01M | 8.10M | 9.64M | |||
| Cost Of Goods | 5.30M | 6.51M | 7.29M | 8.60M | 9.29M | |||
| Gross Profit | -903.30K | -1.99M | -281.00K | -494.00K | 349.00K | |||
| Operating Expenses | 2.79M | 2.60M | 2.47M | 3.06M | 3.21M | |||
| Research and Development | 138.80K | 283.90K | 240.00K | 186.00K | 319.00K | |||
| Selling, General, and Administrative Expenses | 2.09M | 1.87M | 2.01M | 2.83M | 2.85M | |||
| Operating Income | -3.69M | -4.59M | -2.75M | -3.55M | -2.86M | |||
| Interest Income/Expense | -115.00K | -147.50K | -327.00K | -424.00K | -539.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -3.66M | -4.74M | -3.08M | -3.97M | -3.40M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -3.66M | -4.74M | -3.08M | -3.97M | -3.40M | |||
| EBITDA | -1.90M | -1.97M | 2.00K | -848.00K | 227.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.58 | -2.71 | -9.09 | -37.78 | -36.84 | |||
| Statistics | ||||||||
| Gross Profit Margin | -20.55% | -43.85% | -4.01% | -6.10% | 3.62% | |||
| Profit Margin | -83.17% | -104.58% | -43.92% | -49.03% | -35.25% | |||
| Operating Profit Margin | -83.98% | -101.32% | -39.25% | -43.79% | -29.67% | |||
All data in USD